868167-60-6

Basic information

• Product Name: 1-iodo-3-Methoxy-5-(trifluoroMethyl)benzene
• Synonyms: 1-iodo-3-Methoxy-5-(trifluoroMethyl)benzene
• CAS NO: 868167-60-6
• Molecular Formula: C8H6F3IO
• Molecular Weight: 302.0323196
• Mol File: 868167-60-6.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-iodo-3-Methoxy-5-(trifluoroMethyl)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-iodo-3-Methoxy-5-(trifluoroMethyl)benzene(868167-60-6)
• EPA Substance Registry System: 1-iodo-3-Methoxy-5-(trifluoroMethyl)benzene(868167-60-6)

Safety Data

• Hazardous Substances Data: 868167-60-6(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
1-iodo-3-Methoxy-5-(trifluoroMethyl)benzene is used as a reagent in organic synthesis for various reactions, such as Suzuki-Miyaura coupling, Buchwald-Hartwig amination, and Sonogashira cross-coupling. Its unique functional groups enable the formation of new chemical bonds and the synthesis of complex organic molecules.
Used in Pharmaceutical Synthesis:
1-iodo-3-Methoxy-5-(trifluoroMethyl)benzene is used as a building block in the synthesis of pharmaceuticals. Its structural features can be incorporated into drug molecules to enhance their biological activity, selectivity, and pharmacokinetic properties.
Used in Agrochemical Synthesis:
1-iodo-3-Methoxy-5-(trifluoroMethyl)benzene is also used in the synthesis of agrochemicals, such as pesticides and herbicides. Its incorporation into these molecules can improve their efficacy, selectivity, and environmental compatibility.
Used in Materials Science:
1-iodo-3-Methoxy-5-(trifluoroMethyl)benzene has potential applications in materials science, particularly in the development of liquid crystals and functional polymers. Its unique molecular structure can contribute to the properties of these materials, such as their optical, electronic, and mechanical characteristics.

Upstream product

• 349-55-3 5-(trifluoromethyl)-m-anisidine 
• 328-79-0 1-methoxy-3-nitro-5-trifluoromethyl-benzene 
• 401-99-0 3,5-dinitrobenzotrifluoride 

Downstream Products

• 1243459-56-4 3-hydroxy-5-(trifluoromethyl)benzonitrile 

Relevant articles and documents

2,3-DIHYDROIMIDAZO[1 ,2-c] PYRIMIDIN-5(1 H)-ONE COMPOUNDS USE AS LP-PLA2 INHIBITORS

Disclosed are 2,3-dihydroimidazo[1,2-c]pyrimidin-5(1H)-one compounds that inhibit Lp-PLA2, processes for their preparation, compositions containing them and their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.

SUBSTITUTED PYRIDONE COMPOUNDS AND METHODS OF USE

The present invention comprises a new class of compounds capable of modulating the c-kit receptor and, accordingly, useful for treatment of c-kit mediated diseases, including various inflammatory, fibrotic and/or mast cell mediated diseases such as mastocytosis. The compounds have a general Formula: (I); wherein A0-3 and R1-6 are defined herein. The invention further comprises pharmaceutical compositions, methods for treatment of c-kit mediated diseases, and intermediates and processes useful for the preparation of compounds of the invention.

CETP INHIBITORS

Compounds of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formu

5-LIPOXYGENASE INHIBITORY THIAZOLES

The invention concerns a thiazole of the formula I, wherein Ar1 is optionally substituted aryl of up to 10 carbon atoms; A is a direct link to X, or is (1-6C)alkylene, (3-6C)alkenylene, (3-6C)alkynylene or cyclo(3-6C)alkylene; X is oxy, thio, sulphinyl, sulphonyl or imino; Ar2 is optionally substituted phenylene, or a 6-membered heterocyclene moiety containing up to three nitrogen atoms; R1 is hydrogen, (1-6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl or substituted (1-4C)alkyl; R2 is hydrogen, (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, substituted (1-4C)alkyl or (2-6C)alkanoyl; Q is optionally substituted thiazolyl; or a pharmaceutically-acceptable salt thereof. The invention also concerns processes for the manufacture of a thiazole of the formula I, or a pharmaceutically-acceptable salt thereof, and pharmaceutical compositions containing said thiazole